Safety advice For external use only
While both target similar mechanisms to aid weight loss, semaglutides extended-release formulation leads to more sustained effects and greater overall weight reduction
3 A gradual dose increase helps your body adjust while minimizing potential side effects
Walker, MD Saint Francis Medical Center NASS Patient Safety Committee Member Cape Girardeau, MO Introduction and Mechanism of Action Glucagon-like peptide-1 (GLP-1) agonists are recognized for their efficacy in managing diabetes mellitus and aiding weight loss.1 They also reduce cardiovascular risk.2,3,4 The mechanism of action involves mimicking GLP-1, an incretin hormone that enhances insulin secretion after an oral glucose load.5,6 Beyond these effects, GLP-1 agonists are involved in inhibiting glucagon secretion, thus stabilizing blood glucose levels
Try our free insurance checker here
View on PubMed Jett L, Lger R, Thibaudeau K, et al